Viron
Boston
About Viron
Viron is a biopharmaceutical company that uses breakthrough discovery and novel technologies to identify and develop patent-pending high-value therapies for currently unarguable porosome protein and lipid targets in cancer, Alzheimer's, diabetes, neurological, digestive, and immune disorders. Breakthroughs in genomics and gene editing technologies, stem cell biology, patient-derived organoids, cryo-electron microscopy, synthetic biology, small molecule screening, and image analysis using AI machine learning and high-throughput screening have transformed the drug discovery landscape.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $75.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2021)
- Website: vironrx.com
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/viron-143548 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.